Animal & Veterinary
Analytical Methods for Melamine and Triazine Analogs
The following methods for detection of melamine/cyanuric acid were developed by FDA's Office of Regulatory Affairs. For additional information or questions regarding them, please contact:
Jonathan Litzau, Forensic Chemistry Center (FCC), US FDA
(513) 679-2700 Ext. 268
Email: jonathan.litzau@fda.hhs.gov
Greg Mercer, Pacific Regional Laboratory – Northwest (PRL-NW), US FDA
(425) 483-4755
Email: greg.mercer@fda.hhs.gov
(Primary contact for “QEdit” reporting option)
Kevin Mulligan, Forensic Chemistry Center (FCC), US FDA
(513) 679-2700 Ext. 238
Email:kevin.mulligan@fda.hhs.gov
GC-MS Screen for the Presence of Melamine, Ammeline, Ammelide and Cyanuric Acid (Version 2.1), May 16, 2007
GC-MS Method for Screening and Confirmation of Melamine and Related Analogs (Version 2), May 7, 2007
The FDA Field laboratories are using LC-MS/MS methods that are capable of determining melamine and cyanuric acid at levels of 0.25 ppm in powdered infant formula and other dairy-containing food products or ingredients. These and a GC/MS method for melamine and its analogues are:
- Melamine Methodology
- Determination of Melamine and Cyanuric Acid Residues in Infant Formula using LC-MS/MS
- Interim Method for Determination of Melamine and Cyanuric Acid Residues in Foods using LC-MS/MS
- GC/MS method for melamine and analogues